Literature DB >> 23173757

Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries.

Usha Sambamoorthi1, Yunsheng Ma, Patricia A Findley, George Rust.   

Abstract

BACKGROUND: The aim of the present study was to examine the association between antidepressant use, diagnosed depression, and new-onset diabetes among elderly Medicare beneficiaries.
METHODS: Longitudinal data from merged survey and claims from the nationally representative Medicare Current Beneficiary Survey(MCBS) from 1999 to 2005 were used. Diabetes incidence was extracted from claims and survey data over a 3-year period. Data regarding depression and antidepressant use over time were obtained. Multivariate logistic regression analysis was used to examine associations between antidepressant use, depression, and new-onset diabetes, adjusted for demographic, socioeconomic, and lifestyle risk factors. Analyses accounted for the complex design of the MCBS.
RESULTS: The incident diabetes rate was 4.8% for those "without depression and without antidepressants" and 9.5% for those with any antidepressant use in all 3 years and diagnosed depression". Compared with Medicare beneficiaries who did not report any antidepressant use, beneficiaries reporting antidepressant use in all 3 years were 50% more likely to have new-onset diabetes. However, when diagnosed depression was entered in the model, there was no significant association between long-term antidepressant use and new-onset diabetes. Medicare beneficiaries with any depression were twice as likely as those without depression to develop diabetes (adjusted odds ratio 2.04; 95% confidence interval 1.51, 2.75).
CONCLUSIONS: Depression independently increased the risk of developing diabetes in the MCBS population, although there is no evidence of an association between antidepressant use and new-onset diabetes. If replicated, these results have significant clinical implications.
© 2012 Wiley Publishing Asia Pty Ltd and Ruijin Hospital, Shanghai Jiaotong University School of Medicine.

Entities:  

Keywords:  antidepressants; depression; diabetes; elderly; epidemiology; 抗抑郁药,抑郁症,糖尿病,老年人,流行病学

Mesh:

Substances:

Year:  2013        PMID: 23173757      PMCID: PMC3594455          DOI: 10.1111/1753-0407.12014

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  21 in total

1.  Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001.

Authors:  Hua Chen; Jaxk H Reeves; Jack E Fincham; William K Kennedy; Jeffrey H Dorfman; Bradley C Martin
Journal:  J Clin Psychiatry       Date:  2006-06       Impact factor: 4.384

2.  Organization of care and diagnosed depression among women veterans.

Authors:  Usha Sambamoorthi; Bevanne Bean-Mayberry; Patricia A Findley; Elizabeth M Yano; Ranjana Banerjea
Journal:  Am J Manag Care       Date:  2010-09       Impact factor: 2.229

3.  Type of antidepressant therapy and risk of type 2 diabetes in people with depression.

Authors:  Lauren C Brown; Sumit R Majumdar; Jeffrey A Johnson
Journal:  Diabetes Res Clin Pract       Date:  2007-08-21       Impact factor: 5.602

4.  Cardiovascular disease and death associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA).

Authors:  Evan Atlantis; Dave A Grayson; Colette Browning; Jane Sims; Hal Kendig
Journal:  Int J Geriatr Psychiatry       Date:  2011-04       Impact factor: 3.485

5.  Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression.

Authors:  Antonio Campayo; Peter de Jonge; Juan F Roy; Pedro Saz; Concepción de la Cámara; Miguel A Quintanilla; Guillermo Marcos; Javier Santabárbara; Antonio Lobo
Journal:  Am J Psychiatry       Date:  2010-02-01       Impact factor: 18.112

6.  Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.

Authors:  Richard R Rubin; Yong Ma; Mark Peyrot; David G Marrero; David W Price; Elizabeth Barrett-Connor; William C Knowler
Journal:  Diabetes Care       Date:  2010-08-30       Impact factor: 19.112

7.  National patterns in antidepressant medication treatment.

Authors:  Mark Olfson; Steven C Marcus
Journal:  Arch Gen Psychiatry       Date:  2009-08

8.  Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.

Authors:  Frank Andersohn; René Schade; Samy Suissa; Edeltraut Garbe
Journal:  Am J Psychiatry       Date:  2009-04-01       Impact factor: 18.112

9.  Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women.

Authors:  Yunsheng Ma; Raji Balasubramanian; Sherry L Pagoto; Kristin L Schneider; Annie L Culver; Barbara Olendzki; Lesley Tinker; Simin Liu; Monika Safford; Deidre M Sepavich; Milagros C Rosal; Judith K Ockene; Mercedes Carnethon; Martha Zorn; James R Hébert
Journal:  Diabetes Care       Date:  2011-09-12       Impact factor: 19.112

Review 10.  Depression and type 2 diabetes over the lifespan: a meta-analysis.

Authors:  Briana Mezuk; William W Eaton; Sandra Albrecht; Sherita Hill Golden
Journal:  Diabetes Care       Date:  2008-12       Impact factor: 17.152

View more
  6 in total

1.  Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase®.

Authors:  Thi Thu Ha Nguyen; Anne Roussin; Vanessa Rousseau; Jean-Louis Montastruc; François Montastruc
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

2.  Concomitant Medication Use and New-Onset Diabetes Among Medicaid Beneficiaries with Chronic Obstructive Pulmonary Disease.

Authors:  Mayank Ajmera; Chan Shen; Usha Sambamoorthi
Journal:  Popul Health Manag       Date:  2016-09-30       Impact factor: 2.459

Review 3.  The comorbidity between depression and diabetes.

Authors:  Bibilola D Oladeji; Oye Gureje
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

4.  Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women's Health Study.

Authors:  Varsha G Vimalananda; Julie R Palmer; Hanna Gerlovin; Lauren A Wise; James L Rosenzweig; Lynn Rosenberg; Edward A Ruiz-Narváez
Journal:  Diabetes Care       Date:  2014-05-01       Impact factor: 19.112

Review 5.  The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysis.

Authors:  Virginio Salvi; Ilaria Grua; Giancarlo Cerveri; Claudio Mencacci; Francesco Barone-Adesi
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

6.  Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.

Authors:  Yen-Hao Tran; Catharina C M Schuiling-Veninga; Jorieke E H Bergman; Henk Groen; Bob Wilffert
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.